Search
JEVTANA 60 MG / 1.5 ML, Solution à diluer pour perfusion
Details
| --- | Description |
|---|---|
| Pack | Flacon de 1.5 ml |
| Strength (Dosage) | 60 MG / 1,5 ML |
| Laboratory | SANOFI AVENTIS MAROC |
| Ingredients | Cabazitaxel |
| Therapeutic class | Cytostatique |
| ATC code | L01CD04 |
| PPH | $4,284.10 |
| PPV | $4,369.00 |
| Refundable | Yes |
| Refund base | $2,204.40 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | En association avec la prednisone ou la prednisolone, JEVTANA est indiqué pour le traitement de patients atteints d'un cancer métastatique de la prostate résistant à la castration (mCRPC) ayant été traités au préalable avec une chimiothérapie à base de docétaxel. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem